Results 101 to 110 of about 2,608,509 (268)
2-Chloro-N6-cyclopentyladenosine: a highly selective agonist at A1 adenosine receptors
Martin J. Lohse +5 more
openalex +1 more source
Simulation and comparative analysis of binding modes of nucleoside and non-nucleoside agonists at the A2B adenosine receptor [PDF]
Diego Dal Ben +4 more
openalex +1 more source
An Adenosine Receptor for Olfaction in Fish
N. Wakisaka +5 more
semanticscholar +1 more source
Mesenchymal stromal cells (MSC) are considered a promising alternative for neuropathic pain (NP) treatment, but underlying mechanisms remain elusive. Huang et al. illustrate that a Npy2r sensory neuron‐related lung–brain axis contributes to MSC analgesia.
Jing Huang +25 more
wiley +1 more source
This study explores honeysuckle‐derived nanovesicles (HNVs) for treating inflammatory bowel disease. Orally administered HNVs alleviates colitis in mice by repairing the gut barrier, reducing inflammation, and restoring a healthy gut microbiota.
Yuanyuan Wang +11 more
wiley +1 more source
Synergy between receptors mediates adenosine release from spinal cord synaptosomes
Catherine M. Cahill +2 more
openalex +2 more sources
Adenosine A2A Receptor mRNA Regulation by Nerve Growth Factor Is TrkA-, Src-, and Ras-dependent via Extracellular Regulated Kinase and Stress-activated Protein Kinase/c-Jun NH2-terminal Kinase [PDF]
Renae L. Malek +3 more
openalex +1 more source
TSHR‐Targeting Nucleic Acid Aptamer Treats Graves' Ophthalmopathy via Novel Allosteric Inhibition
This study presents YC3, a novel inhibitory TSHR‐targeting aptamer, as a promising therapeutic for Graves' ophthalmopathy (GO). YC3 suppresses pathological phenotypes in human orbital fibroblasts and improves outcomes in GO mice by binding to a previously unidentified allosteric site on TSHR, demonstrating the potential of aptamers in advancing ...
Yanchen Zhang +16 more
wiley +1 more source
Adenosine receptor signalling in Alzheimer's disease. [PDF]
Trinh PNH +4 more
europepmc +1 more source

